Contract Pharma

Modified Release Tablets: Strategies for Optimising Drug Delivery

In the evolving landscape of pharmaceutical development, modified release (MR) tablets have emerged as a cornerstone technology for improving therapeutic outcomes and patient compliance. Unlike ...
Medscape

Efficacy and Tolerability of Oxycodone Hydrochloride Controlled-Release Tablets in Moderate to Severe Cancer Pain

Between April 2005 and December 2005, 216 patients (142 inpatients and 74 outpatients) from ten hospitals were enrolled. There were 126 male and 90 female patients (a ratio of 1.4:1). Of the 216 ...
Healio

Novel therapy for Prader-Willi syndrome advances to phase 3 trial

Please provide your email address to receive an email when new articles are posted on . Two presentations at the 2018 Foundation for Prader-Willi Research Annual Conference in Las Vegas detailed ...
Nasdaq

Soleno Therapeutics Announces Late-Breaking Oral Presentation with Body Composition Results from Phase III DESTINY PWS Trial of DCCR in Prader-Willi Syndrome at ObesityWeek ...

The abstract is available on the ObesityWeek website and can be accessed directly here. About Diazoxide Choline Controlled-Release (DCCR) TabletDiazoxide Choline Controlled-Release tablet is a novel, ...
Science Daily

Ketamine slow-release tablet reduces symptoms of severe depression: Clinical trial

A slow-release, tablet form of ketamine with minimal side-effects has the potential to make treatment more affordable and accessible. A new tablet form of ketamine has shown promise in treating severe ...